0 CHECKOUT

New Zealand Pharmaceuticals and Healthcare Report Q4 2015

  • ID: 3341866
  • August 2015
  • Region: New Zealand
  • 85 pages
  • Business Monitor International
1 of 4

FEATURED COMPANIES

  • Douglas Pharmaceuticals
  • Pfizer New Zealand
  • MORE

Over the forecast period New Zealand will continue to present a gradually deteriorating operating environment for drugmakers. Pharmac's limited and oversubscribed budget, will not allow for significant expansion in the volume and value of the pharmaceutical market as prices are held down.

However, if ratified the Trans Pacific Partnership would likely place great restraints on Pharmac's ability to do so and see New Zealand's regulators forced to accept higher prices for high value pharmaceuticals and biologics. However, a rapidly ageing population and already record levels of insurance claims suggests that far greater private sector participation will be necessary to support such prices.

Headline Expenditure Forecasts
- Pharmaceuticals: NZD1.45bn (USD1.20bn) in 2014 to NZD1.48bn (USD1.07bn) in 2015; 2% in local currency terms and -11.4% in US dollar terms. Forecast unchanged from last quarter.

- Healthcare: NZD22.57bn (USD18.72bn) in 2014 to NZD23.10bn (USD16.63bn) in 2015; 2.3% in local currency terms and -11.1% in US dollar terms. Forecast unchanged from last quarter.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Douglas Pharmaceuticals
  • Pfizer New Zealand
  • MORE

SWOT

Political

Economic

Operational Risk

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (New Zealand 2011-2019)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (New Zealand 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (New Zealand 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (New Zealand 2011-2019)

Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (New Zealand 2011-2019)

OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (New Zealand 2011-2019)

Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (New Zealand 2011-2019)

Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (New Zealand 2011-2019)

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (New Zealand 2013-2019)

Key Risks To The Forecast Scenario

Macroeconomic Forecasts

Economic Analysis
Table: Economic Activity (New Zealand 2010-2019)

Industry Risk Reward Ratings

Asia Pacific Risk/Reward - Q4 2015

New Zealand Risk/Reward Index

Rewards

Risks

Market Overview

Industry Trends And Developments

Epidemiology

Healthcare Sector

Infrastructure
Table: Healthcare Resources (New Zealand 2009-2014)
Table: Healthcare Activity (New Zealand 2009-2014)
Table: Healthcare Personnel (New Zealand 2009-2014)

Distribution Channels
Table: Pharmacybrands Stores By Company & Region, 2010

Research And Development

Clinical Trials Sector

Regulatory Development

Regulatory Regime

Intellectual Property Regime

Pricing & Reimbursement
Table: Leading Therapeutic Groups By PHARMAC Expenditure (NZDmn), 2005-2010
Table: Top 20 Medicines By Ex-Manufacturer Cost To PHARMAC In The Year Ending June 2010 (NZDmn)
Table: Top 20 Medicines Reimbursed By PHARMAC According To Prescription Numbers In The Year Ending June 2010

Recent Regulatory Developments

Competitive Landscape

Company Profile

Southern Cross Healthcare Group

Douglas Pharmaceuticals

New Zealand Pharmaceuticals

Pfizer New Zealand

Demographic Forecast
Table: Population Headline Indicators (New Zealand 1990-2025)
Table: Key Population Ratios (New Zealand 1990-2025)
Table: Urban/Rural Population & Life Expectancy (New Zealand 1990-2025)
Table: Population By Age Group (New Zealand 1990-2025)
Table: Population By Age Group % (New Zealand 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 4

Southern Cross Healthcare Group
Douglas Pharmaceuticals
New Zealand Pharmaceuticals
Pfizer New Zealand

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Amneal Pharmaceuticals LLC.
  • Amgen Inc.
  • LEO Laboratories Ltd.
  • Pfizer Inc.
  • Roche Diagnostics Ltd.
  • Merck & Co., Inc.
  • Sanofi S.A.